In concordance with the IL-18 levels, both Balb/c and Nlrp1b1-transgenic mice showed reduced hepatic steatosis and reduced dyslipidemia when fed with the HFD than obese Wt C57BL/6 mice. This evidence concerns the gene IL18 and fatty liver disease.